In breast cancer cell lines, CCL18 derived from TAMs activates NF‐κB and thereby induces EMT‐like changes including spindle‐shaped morphology, E‐cadherin‐to‐vimentin switch, and increased invasive properties (Su et al., 2014). This evidence concerns the gene CCL18 and breast cancer.